MaaT-033

N/A

Report date: 2026/04/04 20:00:24

Base Information

Drug NameMaaT-033
Drug Alias NameMaaT-033
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacementsGastrointestinal microbiome modulators
TargetsNot applicable
Therapy Area/IndicationsAxial SpondyloarthritisHematologic DiseasesAmyotrophic Lateral Sclerosis +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumNetherlandsGermany +[6
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMaat Pharma
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAxial SpondyloarthritisHematologic DiseasesAmyotrophic Lateral Sclerosis +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A